T1	Participants 65 77	737 patients
T2	Participants 94 113	malignant lymphoma.
T3	Participants 149 161	737 patients
T4	Participants 178 200	malignant lymphoma (ML
T5	Participants 656 687	Four hundred forty-two patients
T6	Participants 942 975	Five hundred fifty-three patients
T7	Participants 1948 1961	aggressive ML
